Ovidrel Pen Choriogonadotropin alfa (rch) Consumer Medicine Information

Size: px
Start display at page:

Download "Ovidrel Pen Choriogonadotropin alfa (rch) Consumer Medicine Information"

Transcription

1 Ovidrel Pen Choriogonadotropin alfa (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Ovidrel. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you using Ovidrel against the benefits it will have for you. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Keep this information with your medicine. You may want to read it again later. What Ovidrel is used for Ovidrel belongs to a family of hormones known as gonadotrophins, which are involved in the normal control of reproduction. The active substance of Ovidrel is choriogonadotropin alfa that is produced in mammalian cells modified by recombinant DNA technology. Ovidrel is used in women undergoing assisted reproductive techniques such as in vitro fertilisation (IVF). Other medicines are given first to bring about the growth and development of several follicles to produce eggs. Follicles are the structures in your ovaries that contain the egg. Ovidrel is then used to ripen (mature) these follicles. Ovidrel is also used in women who do not produce eggs (anovulation), or who produce too few eggs (oligoovulation). It is used to trigger the release of eggs (ovulation), after other medicines have been used to develop the follicles. Your doctor may prescribe Ovidrel for another reason. Ask your doctor if you have any questions about why Ovidrel has been prescribed for you. Ovidrel is not addictive. This medicine is available only with a doctor's prescription. Before you use Ovidrel When you must not use it Do not use Ovidrel if: you have a history of allergy to choriogonadotropin alfa, or a similar medicine, or any other inactive ingredients (listed at the end of this leaflet). Symptoms of an allergic reaction to Ovidrel may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. Do not take Ovidrel if you have, or have had, any of the following medical conditions: your ovaries are unable to be stimulated to produce eggs (primary ovarian failure or premature menopause) uncontrolled thyroid or adrenal gland disease a tumour of the hypothalamus or pituitary gland ovarian enlargement or one or more large ovarian cysts cancer of your ovaries, uterus (womb) or breasts fibroid tumours in your uterus which would make pregnancy impossible if you have been through menopause Ovidrel should not be used in the elderly or in children. Do not take Ovidrel after the expiry date printed on the pack. Do not take Ovidrel if the packaging is torn or shows signs of tampering. If your medicine has expired or is damaged, return it to your pharmacist for disposal. If you are not sure whether you should start using Ovidrel, contact your doctor. Before you start to use it Your doctor will assess you and your partner's infertility. This may include tests for other medical conditions, which may interfere with your ability to become pregnant. If necessary, other medical conditions may be treated before starting infertility treatments and Ovidrel. Tell your doctor if you have or have had any other pre-existing medical conditions. Treatment with Ovidrel may increase your risk of developing a condition OVIDREL PEN 1

2 called ovarian hyperstimulation syndrome (OHSS). This is when the ovaries over react to the hormonal treatment and develop too many follicles. The most common symptom is stomach pain. During stimulation your doctor will monitor your treatment by use of ultrasound and blood tests to measure oestrogen levels. This will help to indicate if you are likely to develop OHSS. If necessary, your doctor will delay or cancel your Ovidrel injection. Compared to natural conception, the frequency of multiple pregnancies and births is increased in patients receiving this treatment. The majority of these are twins. In assisted reproduction techniques, the number of babies is related to the number of embryos replaced. Please discuss with your doctor. There may be a slightly increased risk of birth defects in women using assisted reproductive technologies. This may be due to maternal age, genetic factors, multiple pregnancies or the assisted reproductive technologies. Talk to your doctor about any concerns you may have before undergoing treatment. Tell your doctor if you or your family have or have had increased risk of developing blood clots e.g. stroke, heart attacks. Taking other medicines Tell your doctor if you are taking any other medicines, including any that you buy without prescription from your pharmacy, supermarket or health food shop. Ovidrel may interfere with the results of a blood or urinary hcg (pregnancy) test for up to 10 days. This may lead to a false positive pregnancy test. How Ovidrel is given Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information contained in this leaflet. Treatment with Ovidrel should be started under the supervision of a specialist doctor experienced in fertility treatment. How much to inject The dose of Ovidrel is one pre-filled pen (250 microgram in 0.5 ml) given as a single injection after stimulation of follicle growth by other medicines. Dosage may need to be varied on the instruction of your doctor and you should be confident in your ability to adjust the dose. Please consult your doctor or pharmacist if you are in any doubt. Your doctor will explain exactly when to give the injection. Each pre-filled pen is for single use only. How to inject Ovidrel is given as an injection under the skin (subcutaneously), usually near your stomach. Ovidrel is intended to be injected by yourself or by your partner. Your doctor or nurse will instruct and assist you in learning the procedure and technique of self-injection. Do not attempt self-injection until you are sure of how to do it. Your partner may be trained to give the injection at home. Your doctor or nurse can also give the injection to you. Where to inject Ovidrel is usually given in the stomach area (except around navel and waistline) or the front of your thigh. Do not inject into any areas in which you feel lumps, firm knots, depressions, pain or discolouration. Talk to your doctor if you find anything unusual when injecting. If you forget to inject Ovidrel You should contact your doctor immediately. It is important that Ovidrel is injected on the correct day and at the correct time as instructed by your doctor. You must inform your doctor if your injection was not given when directed. Ask your doctor if you are not sure what to do or have trouble remembering to inject your medicine. If you inject too much Immediately contact your doctor or the Poisons Information Centre (In Australia telephone In New Zealand telephone ) if you are concerned that you have given yourself too much Ovidrel. While you are using Ovidrel Things you must do Tell your doctor if you start taking any new medication while using Ovidrel. Things you must not do Do not give this medicine to anyone else, even if their symptoms seem similar to yours or if they have the same condition as you. Do not use Ovidrel to treat any other complaints unless your doctor says to. Do not stop Ovidrel or change the dose without checking with your doctor. OVIDREL PEN 2

3 Side effects Tell your doctor as soon as possible if you do not feel well while you are taking Ovidrel. Tell your doctor immediately if you experience any of the following: Early signs of ovarian hyperstimulation syndrome (OHSS) which includes severe stomach pain, nausea, vomiting, diarrhoea, shortness of breath and low urine production. Tell your doctor if you notice any of the following and they worry you: Common side effects: injection site soreness/redness headache tiredness nausea/vomiting, abdominal pain rash Uncommon side effects: diarrhoea depression irritability restlessness breast pain severe OHSS mild allergic reaction warning signs of blood clots (such as pain, warmth, redness, numbness or tingling in arm or leg) warning signs of stroke or heart attack Other side effects not listed above may also occur in some patients. Tell your doctor if you notice anything else that is making you feel unwell. Do not be alarmed by this list of possible side effects. You may not experience any of them. After using Ovidrel Storage Keep this medicine where young children cannot reach it. Ovidrel must be stored at 2 C to 8 C (Refrigerate. Do not freeze) in its original container. Product is for single patient use in one patient only. Contains no antimicrobial preservative. Discard any residue. Disposal After injecting, you should discard the pen even if you have not injected all its contents. Pen and needle should be discarded in an appropriate disposal unit. Product description What it looks like Ovidrel is supplied in a pre-filled pen. Ingredients Active ingredient: choriogonadotropin alfa Inactive Ingredients: mannitol sodium phosphate - monobasic sodium phosphate - dibasic dihydrate phosphoric acid sodium hydroxide poloxamer methionine water for injections Manufacturer/Supplier Ovidrel is supplied in Australia by: Merck Serono Australia Pty Ltd 3-4/25 Frenchs Forest Road Frenchs Forest NSW 2086 Ovidrel is supplied in New Zealand by: Healthcare Logistics 58 Richard Pearse Drive Airport Oaks, Auckland The Australian registration number for: Ovidrel 250 microgram Solution for Injection pre-filled pen is AUST R This leaflet was amended in May A OVIDREL PEN 3

4 HOW TO USE THE OVIDREL PRE-FILLED PEN CONTENTS 1. How to use the Ovidrel pre-filled pen 2. Before you start using your pre-filled pen 3. Getting your pre-filled pen ready for injection 4. Setting the dose How to set the dose to Injecting the dose 6. After the injection Instructions for use 1. How to use the Ovidrel pre-filled pen Before starting to use your pre-filled pen, please read these instructions the whole way through. Only use this pen for yourself, do not let anyone else use it. Inject Ovidrel as your doctor or nurse taught you. This pen is for single use only. 2. Before you start using your pre-filled pen 2.1 Wash your hands It is important that your hands and the things you use to get your pen ready are as clean as possible. 2.2 Find a clean area A good place is a clean table or surface. 2.3 Get together everything you need and lay them out: alcohol swabs the pre-filled pen a needle. Below is a diagram that shows what the pre-filled pen looks like along with the labels of the components: 1. dose setting knob 2. dose display 3. plunger piston 4. reservoir holder 5. threaded needle connector 6. pen cap 7. removable needle 8. inner needle shield 9. outer needle cap 10. peel-off seal tab OVIDREL PEN 4

5 3. Getting your pre-filled pen ready for injection 3.1 Take off the pen cap 3.2 Put on a needle Take the needle - only use the single use needle supplied with the Ovidrel pre-filled pen. Check that the peel-off seal on the outer needle cap is not damaged or loose. CAUTION: If the peel-off seal is damaged or loose, do not use the needle and get another one. Throw away the unused needle with the outer needle cap still on. Ask your pharmacist how to dispose of needles that are no longer required. Pull off the peel-off seal. Hold the outer needle cap firmly. Press the threaded tip of the pen into the outer needle cap and screw the outer needle cap on until it is firmly fixed. Remove the outer needle cap by pulling it gently. Leave the inner needle shield in position. Do not throw away the outer needle cap; you will need it for removing the needle from the pre-filled pen after your injection. 3.3 First remove any large air bubbles Look carefully at the reservoir holder. If you don t notice a large air bubble, the pre-filled pen is ready for use. Please go straight to step 4. Setting the dose to 250. OVIDREL PEN 5

6 An air bubble is large if it fills the tip of the reservoir holder when holding the pre-filled pen with the needle pointing upwards (see picture). If you see a large air bubble inside the reservoir holder you need to remove it. There may be some small air bubbles that stick to the inner wall of the reservoir holder left in the pen. Do not be concerned about small air bubbles; they do not need to be removed. To remove a large air bubble: 1. Gently turn the dose setting knob clockwise until you see a dot ( ) in the dose display. If you pass this position, simply turn the dose setting knob back to the dot ( ). 2. Then take off the inner needle shield and hold the pen with the needle pointing upwards. OVIDREL PEN 6

7 3. Tap the reservoir holder gently with your finger so that any air bubbles rise up towards the needle. With the needle still pointing upwards, slowly press the dose setting knob as far as it will go. 4. A drop of liquid must appear at the tip of the needle; this shows that your pre-filled pen is ready for injection. 5. If you do not see any liquid, you may try a second time (you may do this a maximum of two times) starting from step 1 of section To remove a large air bubble above. 4. Setting the dose to 250 Gently turn the dose setting knob clockwise. The dose display will show a straight line and you have to keep turning until you can read the number 250. Do not push or pull the dose setting button while you turn it. The dose display should read 250, as shown in the figure below. 5. Injecting the dose 5.1 Choose the place to give the injection where your doctor or nurse has told you. 5.2 Clean the skin at the injection site by wiping it with an alcohol swab. 5.3 Check again that the number in the dose display reads 250. If it doesn t, you must adjust it (see step 4. Setting the dose to 250 ) 5.4 Remove carefully the inner needle shield and throw it away, if not already done in step 3.3 First remove any large air bubbles. OVIDREL PEN 7

8 5.5 Inject the dose as you were trained to by your doctor or nurse. Firstly, slowly push the needle into the skin and then secondly press the dose setting knob in as far as it will go, as shown in the picture below. The dose number shown in the dose display will turn back to 0. This shows that the complete dose was delivered. You must keep the needle under the skin with the dose setting knob pressed down for at least 10 seconds. After 10 seconds, keep the dose setting knob pressed down, and take the needle out of your skin. 6. After the injection 6.1 Check that the dose display reads 0 This confirms that the dose has been fully delivered. Do not attempt to inject a second time. In case the dose display doesn t read 0, please contact your doctor or pharmacist. 6.2 Taking off the needle Hold the pre-filled pen firmly by the reservoir holder. Carefully put the outer needle cap onto the needle. OVIDREL PEN 8

9 Then grip the outer needle cap and unscrew the needle. Be careful not to prick yourself with the needle. Now put the pen cap back onto the pen. 6.3 Disposal Use each needle and pen only once. Once you have finished your injection, dispose of the used needle safely, and discard the pen. It is best to put it back into its original package. Medicines should not be disposed of via wastewater or household waste. When the pen is empty, ask your pharmacist how to dispose of it. OVIDREL PEN 9

GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information

GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about GONAL-f. It does

More information

GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch])

GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all

More information

GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch])

GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about GONALf. It does

More information

GONAL-f (follitropin alfa [rch]) solution for injection

GONAL-f (follitropin alfa [rch]) solution for injection (follitropin alfa [rch]) solution for injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information.

More information

Follitropin alfa (rch)/lutropin alfa (rch) Powder for Injection. This leaflet answers some common questions about PERGOVERIS.

Follitropin alfa (rch)/lutropin alfa (rch) Powder for Injection. This leaflet answers some common questions about PERGOVERIS. PERGOVERIS 150 IU / 75 IU Follitropin alfa (rch)/lutropin alfa (rch) Powder for Injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PERGOVERIS.

More information

LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information

LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take

More information

LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information

LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take

More information

LUVERIS 75 IU Lutropin alfa (rch)

LUVERIS 75 IU Lutropin alfa (rch) LUVERIS 75 IU Lutropin alfa (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take

More information

Instructions For Use. SOLUTION FOR INJECTION IN PRE-FILLED PEN 250 micrograms

Instructions For Use. SOLUTION FOR INJECTION IN PRE-FILLED PEN 250 micrograms Instructions For Use SOLUTION FOR INJECTION IN PRE-FILLED PEN 250 micrograms Contents 1. How to use your Ovitrelle pre-filled pen 2. Before you start using your Ovitrelle pre-filled pen 3. Getting your

More information

Bemfola. What is in this leaflet. What is Bemfola used for. Before you are given. Bemfola

Bemfola. What is in this leaflet. What is Bemfola used for. Before you are given. Bemfola Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the

More information

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about CRINONE.

More information

PUREGON follitropin beta[rch]

PUREGON follitropin beta[rch] PUREGON follitropin beta[rch] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PUREGON. It does not contain all the available information. It does

More information

PUREGON follitropin beta[rch]

PUREGON follitropin beta[rch] PUREGON follitropin beta[rch] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PUREGON. It does not contain all the available information. It does

More information

Pregnyl Human chorionic gonadotrophin (hcg)

Pregnyl Human chorionic gonadotrophin (hcg) Pregnyl Human chorionic gonadotrophin (hcg) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Pregnyl. It does not contain all the available information.

More information

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about CRINONE.

More information

ELONVA Corifollitropin alfa (rch) Consumer Medicine Information

ELONVA Corifollitropin alfa (rch) Consumer Medicine Information ELONVA Corifollitropin alfa (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ELONVA. It does not contain all the available information. It does

More information

PRE-FILLED PEN 300 IU/0.5 ml N F

PRE-FILLED PEN 300 IU/0.5 ml N F PRE-FILLED PEN 300 IU/0.5 ml N1990207F PRE-FILLED PEN 300 IU/0.5 ml Instructions for use 300 IU/0.5 ml (22 micrograms/0.5 ml) Contents 1. How to use the GONAL-f pre-filled pen 2. How to use your GONAL-f

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Bemfola 75 IU/0.125 ml solution for injection in a pre-filled pen Bemfola 150 IU/0.25 ml solution for injection in a pre-filled pen Bemfola 225 IU/0.375 ml solution

More information

How to use your Pergoveris pre-filled pen

How to use your Pergoveris pre-filled pen How to use your Pergoveris pre-filled pen Information in this user guide is based on the European product information for Pergoveris. It is not country specific and may vary from country to country. Please

More information

How to use your gonal-f pre-filled pen

How to use your gonal-f pre-filled pen How to use your gonal-f pre-filled pen Information in this user guide is based on the European product information for Gonal-f. It is not country specific and may vary from country to country. Please always

More information

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration. Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration. Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain

More information

FIRAZYR Icatibant acetate

FIRAZYR Icatibant acetate Icatibant acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the place of

More information

AIMOVIG TM solution for injection in pre-filled pen erenumab Consumer Medicine Information

AIMOVIG TM solution for injection in pre-filled pen erenumab Consumer Medicine Information This medicine is subject to additional monitoring in Australia. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side

More information

AIMOVIG solution for injection in pre-filled pen

AIMOVIG solution for injection in pre-filled pen This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side effects to

More information

DALACIN C PHOSPHATE Injection Clindamycin phosphate

DALACIN C PHOSPHATE Injection Clindamycin phosphate DALACIN C PHOSPHATE Injection Clindamycin phosphate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Dalacin C Phosphate injection. It does not contain

More information

Package leaflet: Information for the user. GONAL-f 450 IU/0.75 ml (33 micrograms/0.75 ml) solution for injection in a pre-filled pen Follitropin alfa

Package leaflet: Information for the user. GONAL-f 450 IU/0.75 ml (33 micrograms/0.75 ml) solution for injection in a pre-filled pen Follitropin alfa Package leaflet: Information for the user GONAL-f 450 IU/0.75 ml (33 micrograms/0.75 ml) solution for injection in a pre-filled pen Follitropin alfa Read all of this leaflet carefully before you start

More information

Package leaflet: Information for the patient. Orgalutran 0.25 mg/0.5 ml solution for injection Ganirelix

Package leaflet: Information for the patient. Orgalutran 0.25 mg/0.5 ml solution for injection Ganirelix Package leaflet: Information for the patient Orgalutran 0.25 mg/0.5 ml solution for injection Ganirelix Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: Information for the user. Bemfola 450 IU/0.75 ml solution for injection in pre-filled pen

Package leaflet: Information for the user. Bemfola 450 IU/0.75 ml solution for injection in pre-filled pen Package leaflet: Information for the user Bemfola 75 IU/0.125 ml solution for injection in pre-filled pen Bemfola 150 IU/0.25 ml solution for injection in pre-filled pen Bemfola 225 IU/0.375 ml solution

More information

ZADITEN Eye Drops 1.0%

ZADITEN Eye Drops 1.0% ZADITEN Eye Drops 1.0% Ketotifen Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use Zaditen Eye Drops. This leaflet answers some common questions about

More information

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. Serc betahistine dihydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Serc. It does not contain all the available information. It does

More information

ZOLADEX 3.6 mg implant SafeSystem Goserelin acetate

ZOLADEX 3.6 mg implant SafeSystem Goserelin acetate ZOLADEX 3.6 mg implant SafeSystem Goserelin acetate Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about ZOLADEX 3.6 mg. It does not

More information

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information TYPHIM Vi Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) What is in the leaflet Consumer Medicine Information This leaflet answers some common questions about TYPHIM Vi. It does not

More information

INFORMATION FOR THE CONSUMER

INFORMATION FOR THE CONSUMER INFORMATION FOR THE CONSUMER This insert provides a summary of the information about CETROTIDE (cetrorelix for injection). If you have any questions or concerns, or want more information about CETROTIDE,

More information

Pregnyl 1500 I.U. powder for solution for injection (Human Chorionic Gonadotrophin) INFORMATION FOR THE USER

Pregnyl 1500 I.U. powder for solution for injection (Human Chorionic Gonadotrophin) INFORMATION FOR THE USER Pregnyl 1500 I.U. powder for solution for injection (Human Chorionic Gonadotrophin) INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet.

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Bemfola 75 IU/0.125 ml solution for injection in pre-filled pen Bemfola 150 IU/0.25 ml solution for injection in pre-filled pen Bemfola 225 IU/0.375 ml solution

More information

Influvac Inactivated influenza vaccine [surface antigen]

Influvac Inactivated influenza vaccine [surface antigen] Influvac Inactivated influenza vaccine [surface antigen] Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about Influvac vaccine. It does not contain

More information

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information RELISTOR Methylnaltrexone bromide, Subcutaneous solution for injection Consumer Medicine Information What is in this leaflet? This leaflet answers some common questions about RELISTOR. It does not contain

More information

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it mercaptopurine 20 mg/ml oral suspension Consumer Medicine Information (CMI) ALLMERCAP What is in this leaflet This leaflet answers some common questions about ALLMERCAP. It does not contain all of the

More information

Before you take. Tell your doctor if you have any of the conditions mentioned below or if you have ever experienced any of these conditions.

Before you take. Tell your doctor if you have any of the conditions mentioned below or if you have ever experienced any of these conditions. This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side effects to

More information

Before you use NovoThirteen. When NovoThirteen should not be used

Before you use NovoThirteen. When NovoThirteen should not be used NovoThirteen 2500 U catridecacog (rys) Recombinant coagulation factor X Consumer Medicine nformation What is in this leaflet What NovoThirteen is used for 1 Before you use NovoThirteen 1 Using NovoThirteen...

More information

How Entecavir GH Works

How Entecavir GH Works entecavir monohydrate tablets ENTECAVIR GH Tablets Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking. This leaflet answers some common questions about. It

More information

ZOLADEX 10.8mg implant SafeSystem Goserelin acetate

ZOLADEX 10.8mg implant SafeSystem Goserelin acetate ZOLADEX 10.8mg implant SafeSystem Goserelin acetate Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about ZOLADEX 10.8mg implant. It does

More information

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. Brolene Eye Drops (BRO-leen) propamidine isethionate Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Brolene. It does not contain all the available

More information

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler NEW ZEALAND CONSUMER MEDICINE INFORMATION Beclazone 50, 100, 250 micrograms CFC-Free Inhaler Beclometasone dipropionate 50, 100, or 250 micrograms per metered dose ( puff ) Please read this leaflet carefully

More information

FLIXOTIDE CFC-FREE INHALER and JUNIOR CFC-FREE INHALER ['PUFFER'] Fluticasone propionate Consumer Medicine Information

FLIXOTIDE CFC-FREE INHALER and JUNIOR CFC-FREE INHALER ['PUFFER'] Fluticasone propionate Consumer Medicine Information FLIXOTIDE CFC-FREE INHALER and JUNIOR CFC-FREE INHALER ['PUFFER'] Fluticasone propionate Consumer Medicine Information Please read this leaflet carefully before you start using Flixotide (CFC-free) Inhaler.

More information

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist. What is in this leaflet DUKORAL Oral inactivated cholera and ETEC vaccine Consumer Medicine Information This leaflet answers some common questions about Dukoral. It does not contain all the available information.

More information

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM.

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM. 1 Consumer Medicine Information paracetamol 1000 mg/100 ml solution for injection What is in this leaflet Please read this leaflet carefully before you are given. This leaflet answers some common questions

More information

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

Bicillin L-A Benzathine benzylpenicillin tetrahydrate Bicillin L-A Benzathine benzylpenicillin tetrahydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Bicillin L- A. It does not contain all the available

More information

BrinzoQuin Eye Drops 1.0%

BrinzoQuin Eye Drops 1.0% BrinzoQuin Eye Drops 1.0% Brinzolamide Consumer Medicine Information What Is In This Leaflet Read this leaflet carefully before you start to use BrinzoQuin Eye Drops. This leaflet has been written to answer

More information

ELTROXIN thyroxine (as anhydrous levothyroxine sodium) 50 micrograms, 100 micrograms tablets

ELTROXIN thyroxine (as anhydrous levothyroxine sodium) 50 micrograms, 100 micrograms tablets ELTROXIN thyroxine (as anhydrous levothyroxine sodium) 50 micrograms, 100 micrograms tablets Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about

More information

What Neulasta is used for

What Neulasta is used for pegfilgrastim (rbe) Consumer Medicine Information What is in this leaflet What Neulasta is used for How it works Before you use it When you must not use it Before you start to use it Taking other medicines

More information

THYROGEN Thyrotropin alfa-rch, powder for injection

THYROGEN Thyrotropin alfa-rch, powder for injection THYROGEN Thyrotropin alfa-rch, powder for injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Thyrogen. It does not contain all the available

More information

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have. Triprim Tablets Trimethoprim Tablets Consumer Medicine Information What is in this leaflet? The leaflet answers some common questions about Triprim tablets. It does not contain all the available information

More information

CIPROXIN HC Ear Drops

CIPROXIN HC Ear Drops CIPROXIN HC Ear Drops Ciprofloxacin and Hydrocortisone CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use. This leaflet answers some common questions

More information

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine. PHOLCODINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains pholcodine. This leaflet is intended to provide information on the active ingredient

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION ANDRODERM Testosterone CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions about Androderm. It does not contain all the available information. It does

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Aimovig 70 mg solution for injection in pre-filled pen erenumab This medicine is subject to additional monitoring. This will allow quick identification of new

More information

REVESTIVE teduglutide Consumer Medicine Information

REVESTIVE teduglutide Consumer Medicine Information teduglutide Consumer Medicine Information What is in this leaflet Please read this leaflet before you start using. This leaflet answers some common questions about. It does not contain all the available

More information

OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation

OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Oxis Turbuhaler. It does not contain

More information

Package leaflet: Information for the user Solvent in vials. Luveris 75 IU powder and solvent for solution for injection Lutropin alfa

Package leaflet: Information for the user Solvent in vials. Luveris 75 IU powder and solvent for solution for injection Lutropin alfa Package leaflet: Information for the user Solvent in vials Luveris 75 IU powder and solvent for solution for injection Lutropin alfa Read all of this leaflet carefully before you start using this medicine

More information

Neulasta pegfilgrastim (rbe) Consumer Medicine Information

Neulasta pegfilgrastim (rbe) Consumer Medicine Information Neulasta pegfilgrastim (rbe) Consumer Medicine Information What is in this booklet This booklet answers some common questions about Neulasta. Please note that this booklet does not contain everything there

More information

Simplotan* tablets Tinidazole (tin-id-azole)

Simplotan* tablets Tinidazole (tin-id-azole) Simplotan* tablets Tinidazole (tin-id-azole) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Simplotan. It does not contain all the available information.

More information

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet

More information

Colofac mebeverine hydrochloride

Colofac mebeverine hydrochloride Colofac mebeverine hydrochloride Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Colofac. It does not contain all the available information.

More information

Perjeta Contains the active ingredient pertuzumab (rch)

Perjeta Contains the active ingredient pertuzumab (rch) Perjeta Contains the active ingredient pertuzumab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Perjeta. It does not contain all the available

More information

Copaxone 20 mg/ml glatiramer acetate

Copaxone 20 mg/ml glatiramer acetate glatiramer acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Copaxone 20 mg/ml. It does not contain all the available information. It does not

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user GONAL-f 1050 IU/1.75 ml (77 micrograms/1.75 ml) powder and solvent for solution for injection Follitropin alfa Read all of this leaflet carefully before you start

More information

PEN USER MANUAL Byetta 5 micrograms solution for injection in pre-filled pen (exenatide)

PEN USER MANUAL Byetta 5 micrograms solution for injection in pre-filled pen (exenatide) PEN USER MANUAL Byetta 5 micrograms solution for injection in pre-filled pen (exenatide) Section 1. WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN Read this section completely before you begin. Then, move

More information

METALYSE Tenecteplase

METALYSE Tenecteplase METALYSE Tenecteplase Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Metalyse. It does not contain all the available information. It does not take

More information

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3 EVOGAM Information for patients 11179 Evogam NZ Patient Brochure Update FA3 Information for patients and caregivers about EVOGAM This booklet is designed to help you follow the training you will have been

More information

Ceclor CD cefaclor monohydrate sustained release tablets

Ceclor CD cefaclor monohydrate sustained release tablets Ceclor CD cefaclor monohydrate sustained release tablets Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Ceclor CD. It does not contain all

More information

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe. CONSUMER MEDICINE INFORMATION Levetiracetam generichealth Levetiracetam tablets What is in this leaflet Please read this leaflet carefully before you take this medicine. This leaflet answers some common

More information

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use Patient Information EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use Read the Patient Information that comes with EGRIFTA before you start to take it and each time you get a refill.

More information

oral solution (pronounced KEPP-ruh ) Contains the active ingredient levetiracetam (pronounced "LEE ve tye RA se tam")

oral solution (pronounced KEPP-ruh ) Contains the active ingredient levetiracetam (pronounced LEE ve tye RA se tam) oral solution (pronounced KEPP-ruh ) Contains the active ingredient levetiracetam (pronounced "LEE ve tye RA se tam") Consumer Medicine Information What is in this leaflet This leaflet answers some common

More information

FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation

FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation Consumer Medicine Information Please read this leaflet carefully before you start taking Flixotide What is in this leaflet?

More information

Please read this leaflet carefully before you start using Fluticasone Cipla Inhaler.

Please read this leaflet carefully before you start using Fluticasone Cipla Inhaler. Inhaler 125 microgram and 250 microgram MDI Fluticasone propionate Consumer Medicine Information Please read this leaflet carefully before you start using Inhaler. What is in this leaflet This leaflet

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Puregon 150 IU/0.18 ml solution for injection Puregon 300 IU/0.36 ml solution for injection Puregon 600 IU/0.72 ml solution for injection Puregon 900 IU/1.08 ml

More information

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine. What is in this leaflet PHENYLEPHRINE New Zealand Consumer Medicine Information The medicine you have purchased contains Phenylephrine. This leaflet is intended to provide information on the active ingredient

More information

HEALTHCARE SUPPLIES SPECIALISTS. Product information. amaproducts.com.au HEALTHCARE SUPPLIES SPECIALISTS

HEALTHCARE SUPPLIES SPECIALISTS. Product information. amaproducts.com.au HEALTHCARE SUPPLIES SPECIALISTS HEALTHCARE SUPPLIES SPECIALISTS Product information HEALTHCARE SUPPLIES SPECIALISTS 1300 558 135 1300 558 137 amaproducts.com.au sales@amaproducts.com.au Afluria Quad Inactivated Quadrivalent Influenza

More information

GenRx Amoxycillin Suspension

GenRx Amoxycillin Suspension GenRx Amoxycillin Suspension Contains the active ingredient, amoxycillin (a-mox-i-sil'lin) For a copy of a large print leaflet, Ph: 1800 195 055 Consumer Medicine Information What is in this leaflet Read

More information

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LUMIGAN eye drops. It does not contain all the available

More information

Aranesp darbepoetin alfa

Aranesp darbepoetin alfa Aranesp darbepoetin alfa Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information.

More information

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM. 1 Consumer Medicine Information Flecainide acetate Tablets 50 mg & 100 mg What is in this leaflet Please read this leaflet carefully before you start taking. This leaflet answers some common questions

More information

Before you use it. When you must not use it

Before you use it. When you must not use it Lipegfilgrastim (rbe) Consumer Medicine Information What is in this booklet This booklet answers some common questions about Lonquex. Please note that this booklet does not contain everything there is

More information

Copaxone 40 mg/ml glatiramer acetate

Copaxone 40 mg/ml glatiramer acetate Copaxone 40 mg/ml glatiramer acetate Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Copaxone 40 mg/ml. It does not contain all the available

More information

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules. Clindamycin hydrochloride Capsules 150 mg What is in this leaflet Consumer Medicine Information TOPICIL Please read this leaflet carefully before you start using Topicil Capsules. This leaflet answers

More information

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet

More information

Ezetimibe Sandoz Ezetimibe 10 mg tablet

Ezetimibe Sandoz Ezetimibe 10 mg tablet Consumer Medicine Information Ezetimibe Sandoz Ezetimibe 10 mg tablet WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ezetimibe Sandoz. It does not contain all the available information.

More information

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate) APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read

More information

APO-Latanoprost Contains the active ingredient latanoprost

APO-Latanoprost Contains the active ingredient latanoprost APO-Latanoprost Contains the active ingredient latanoprost Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before

More information

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

If you have any concerns about taking this medicine, ask your doctor or pharmacist. EZETROL ezetimibe 10 mg tablet What is in this leaflet This leaflet answers some common questions about EZETROL. It does not contain all the available information. It does not take the place of talking

More information

EVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11

EVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11 EVOGAM Information for patients 11881 Evogam 2014 NZ Patient Brochure Update v11 Information for patients and caregivers about EVOGAM This booklet is designed to help you follow the training you will have

More information

INSTRUCTIONS FOR USE TYMLOS (tim lows ) (abaloparatide) injection, for subcutaneous use

INSTRUCTIONS FOR USE TYMLOS (tim lows ) (abaloparatide) injection, for subcutaneous use INSTRUCTIONS FOR USE TYMLOS (tim lows ) (abaloparatide) injection, for subcutaneous use Instructions for Use Read and follow this Instructions for Use so that you inject TYMLOS pen the right way. Call

More information

FLIXONASE NASULE DROPS

FLIXONASE NASULE DROPS FLIXONASE NASULE DROPS Fluticasone propionate Consumer Medicine Information Patient's Name First Address Line Second Address Line What is in this leaflet? Please read this leaflet carefully before taking

More information

VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine

VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VIVAXIM.

More information

Beclazone CFC-Free Inhaler

Beclazone CFC-Free Inhaler NEW ZEALAND CONSUMER MEDICINE INFORMATION Beclazone CFC-Free Inhaler Beclometasone dipropionate 50, 100, or 250 micrograms per metered dose ( puff ) Please read this leaflet carefully before you start

More information

Before you are given CYRAMZA. When you must not be given it

Before you are given CYRAMZA. When you must not be given it Ramucirumab (rmc) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place of

More information

Cap Clip Rubber Seal Plunger Pen Body Dose Window

Cap Clip Rubber Seal Plunger Pen Body Dose Window Instructions for Use Humalog 100 units/ml Junior KwikPen, solution for injection in a pre-filled pen insulin lispro PLEASE READ THESE INSTRUCTIONS BEFORE USE Read the Instructions for Use before you start

More information

It does not take the place of talking to your doctor or pharmacist.

It does not take the place of talking to your doctor or pharmacist. ZOMIG Zolmitriptan Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about Zomig. It does not contain all the information that is known

More information